Browse by Poster Presenter

Skip to main content

ASCPT 2023 Annual Meeting Main banner

Tweets by ASCPT 2023 Annual Meeting

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

C
Caratzas, Eleni

University of North Carolina at Chapel Hill Janssen: Pharmaceutical Companies of Johnson & Johnson
EP-036 - ESTIMATING TARGET ENGAGEMENT USING SINGLE POST-DOSE TIMEPOINT TO SUPPORT FURTHER CLINICAL DEVELOPMENT.
Eleni Caratzas
Favorite
Cardona, Panli

Amgen Inc.
EP-005 - AN OPEN-LABEL BIOEQUIVALENCE STUDY IN HEALTHY VOLUNTEERS TO COMPARE THE PHARMACOKINETICS OF TWO DIFFERENT TABLET STRENGTHS OF SOTORASIB.
Panli Cardona
Favorite
EP-006 - AN OPEN-LABEL STUDY TO ASSESS THE EFFECT OF COADMINISTRATION OF SOTORASIB ON THE PHARMACOKINETICS OF ROSUVASTATIN, A BREAST CANCER RESISTANCE PROTEIN SUBSTRATE, IN HEALTHY SUBJECTS.
Panli Cardona
Favorite
Carrasquilla, Santiago

US Food and Drug Administration
PI-020 - IMPACT OF TYROSINE KINASE INHIBITOR (TKI) DOSAGE MODIFICATIONS ON PROGRESSION-FREE SURVIVAL (PFS) IN THE TREATMENT OF EGFR-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC).
Santiago Carrasquilla
Favorite
Cascorbi, Ingolf

University of Kiel
E-002 - FURTHER EVIDENCE ON ABCB1 DRUG TRANSPORTER IN THE RESPONSE TO TEMOZOLOMIDE, CARMUSTINE AND LOMUSTINE IN GLIOBLASTOMA MULTIFORME.
Ingolf Cascorbi
Favorite
Chang, Hsuan Ping

University at Buffalo
LB-008 - DEVELOPMENT OF HOLISTIC EXPOSURE-TOXICITY RELATIONSHIPS FOR MMAE-BASED ADCS: A GENERALIZED PK/PD MODEL.
Hsuan Ping Chang
Favorite
Chang, Vincent

Gilead Sciences
PII-020 - A MATHEMATICAL MODEL FOR SELECTING REGIMEN COMPOSITION AND DURATION BASED ON PHENOTYPE FOR PATIENTS WITH DRUG-SUSCEPTIBLE TUBERCULOSIS.
Vincent Chang
Favorite
PII-065 - OPTIMAL DOSING OF RIFAPENTINE IN NOVEL 4-MONTH HIGH-DOSE RIFAPENTINE WITH MOXIFLOXACIN REGIMEN FOR THE TREATMENT OF DRUG-SUSCEPTIBLE TUBERCULOSIS.
Vincent Chang
Favorite
PWII-002 - A MATHEMATICAL MODEL FOR SELECTING REGIMEN COMPOSITION AND DURATION BASED ON PHENOTYPE FOR PATIENTS WITH DRUG-SUSCEPTIBLE TUBERCULOSIS.
Vincent Chang
Favorite
Chan, Sze Wa

Caritas Institute of Higher Education
EP-007 - CENTRAL ADMINISTRATION OF COCAINE- AND AMPHETAMINE-REGULATED TRANSCRIPT PEPTIDE REDUCES CISPLATIN-INDUCED EMESIS AND C-FOS EXPRESSION IN SUNCUS MURINUS.
Sze Wa Chan
Favorite
Chekka, Lakshmi Manasa

Koniag Government Services
EP-028 - EVALUATING THE UTILITY OF PROTEOMICS FOR THE IDENTIFICATION OF CIRCULATING PHARMACODYNAMIC BIOMARKERS OF IFNΒ-1A BIOLOGICS.
Lakshmi Manasa Chekka
Favorite
Chen, Buyun

Gilead Sciences
PII-096 - MODEL INFORMED DRUG INTERACTION STUDY DESIGN FOR VESATOLIMOD AND CYP3A/P-GP MODULATORS USING PBPK.
Buyun Chen
Favorite
Chen, Ying

Pfizer
PI-043 - CHARACTERIZATION OF GEMTUZUMAB OZOGAMICIN PHARMACOKINETICS IN ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA FOLLOWING FRACTIONATED DOSING REGIMEN.
Ying Chen
Favorite
PII-053 - CONCENTRATION-QT MODELING ANALYSIS OF GEMTUZUMAB OZOGAMICIN FOLLOWING FRACTIONATED DOSING REGIMEN IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA.
Ying Chen
Favorite
Cheruvu, Hanumanth

Parexel International
EP-021 - PBPK MODELING OF A NARROW THERAPEUTIC INDEX DRUG AND APPLICATION IN PREDICTING DOSE ESCALATION SCENARIOS, FOOD EFFECT, DDI AND SPECIAL POPULATION.
Hanumanth Cheruvu
Favorite
Cheung, Kathy

Genentech
PI-092 - RECENT TRENDS IN PEDIATRIC DOSING STRATEGY FROM 2000-2019: A NATURAL LANGUAGE PROCESSING/DRUG LABEL ANALYSIS.
Kathy Cheung
Favorite
PWIV-002 - RECENT TRENDS IN PEDIATRIC DOSING STRATEGY FROM 2000-2019: A NATURAL LANGUAGE PROCESSING/DRUG LABEL ANALYSIS.
Kathy Cheung
Favorite
Chevalier, Rachel

Children's Mercy Kansas City
PI-042 - BUDESONIDE EMBEDDED ALGINATE THIN FILMS SHOW TUNABLE SUSTAINED RELEASE.
Rachel Chevalier
Favorite
Chicoine, Noah

Northeastern University
PI-053 - DEVELOPING A MECHANISTIC MODEL OF IL-15 MEDIATED NK CELL PROLIFERATION WITH IMPLICATIONS IN IMPROVING CAR NK CELL THERAPY EFFICACY.
Noah Chicoine
Favorite
Chowdhury, S M Atiqur

Takeda Development Center Americas Inc.
PI-012 - CLINICAL EFFICACY OF CAR-T AND CAR-NK FOR THE TREATMENT OF HEMATOLOGIC AND SOLID TUMOR MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS.
S M Atiqur Chowdhury
Favorite
Chung, Woo Kyung

Seoul National University Hospital
PII-011 - DRUG-DRUG INTERACTION BETWEEN THE NOVEL SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR, DWP16001, WITH GEMIGLIPTIN AND METFORMIN IN HEALTHY SUBJECTS.
Woo Kyung Chung
Favorite
Cleary, Yumi

F.Hoffmann-La Roche Ltd.
EP-035 - MECHANISTIC POPULATION PHARMACOKINETIC MODELLING OF RISDIPLAM FOR EXTRAPOLATION OF EXPOSURE AND CYP3A DRUG-DRUG INTERACTION IN NEONATES WITH SPINAL MUSCULAR ATROPHY.
Yumi Cleary
Favorite
Collins, Joseph

University of Florida
PT-025 - A NOVEL REGULATORY VARIANT PROMOTES CYP2D6 ALTERNATIVE SPLICING AND REDUCES FULL-LENGTH CYP2D6 PROTEIN LEVELS IN LIVER SAMPLES.
Joseph Collins
Favorite
Collins, Kimberly

Critical Path Institute
LB-002 - RESIDUAL C-PEPTIDE IS ASSOCIATED WITH LOWER HYPOGLYCEMIA RISK IN NEW-ONSET TYPE 1 DIABETES – A POOLED ANALYSIS OF 2780 ADULTS AND CHILDREN.
Kimberly Collins
Favorite
Corriere, Meghan

Vanderbilt University
PT-013 - CONCURRENT GABAPENTIN AND OPIOID USE AND RISK OF MORTALITY IN MEDICARE RECIPIENTS WITH NON-CANCER PAIN.
Meghan Corriere
Favorite
RWE-002 - CONCURRENT GABAPENTIN AND OPIOID USE AND RISK OF MORTALITY IN MEDICARE RECIPIENTS WITH NON-CANCER PAIN.
Meghan Corriere
Favorite